Scinovia is an FDA registered manufacturer. Several VU-FLOW units are being scheduled for comparative clinical studies in early 2022. Surgeons from diverse therapies have shown strong interest in exploring ways that VUFLOW could help in various procedures.
Organizations Involved
Lockheed Martin, U.S. EPA, NASA, Merck, Roche, Houston Methodist, University of Cincinnati, The University of Texas, Ohio State University, Duke University, North Carolina State University, Virginia Tech, IBM, SquareD, 3Com, Cisco Systems
Founders
Jim Sund, Randall K. Wolf, Jeff Haag
Company Description
revolutionary non-contact, real-time, blood flow speeds in vessels for millions of surgeries